Utility of different outcome measures for the nitroglycerin model of migraine in mice.

Abstract

INTRODUCTION:

Majority of the work for establishing nitroglycerin (NTG)-induced migraine models in animals was done in rats, though recently some studies in mice were also reported. Different special formulations of NTG were investigated in various studies; however, NTG treated groups were often compared to simple saline treated control groups. The aim of the present studies was to critically assess the utility of a panel of potential outcome measures in mice by revisiting previous findings and investigating endpoints that have not been tested in mice yet.

METHODS:

We investigated two NTG formulations, Nitrolingual and Nitro Pohl, at an intraperitoneal dose of 10mg/kg, in comparison with relevant vehicle controls, and evaluated the following outcome measures: light aversive behaviour, cranial blood perfusion by laser Doppler imaging, number of c-Fos- and neuronal nitrogen monoxide synthase (nNOS)-immunoreactive neurons in the trigeminal nucleus caudalis (TNC) and trigeminal ganglia, thermal hyperalgesia and tactile allodynia of the hind paw and orofacial pain hypersensitivity.

RESULTS:

We could not confirm previous reports of significant NTG-induced changes in light aversion and cranial blood perfusion of mice but we observed considerable effects elicited by the vehicle of Nitrolingual. In contrast, the vehicle of Nitro Pohl was apparently inert. Increased c-Fos expression in the TNC, thermal hyperalgesia, tactile allodynia and orofacial hypersensitivity were apparently good endpoints in mice that were increased by NTG-administration. The NTG-induced increase in c-Fos expression was prevented by topiramate but not by sumatriptan treatment. However, the NTG-induced orofacial hypersensitivity was dose dependently attenuated by sumatriptan.

DISCUSSION:

Our results pointed to utilisable NTG formulations and outcome measures for NTG-induced migraine models in mice. Pending further cross-validation with positive and negative control drugs in these mouse models and in the human NTG models of migraine, these tests might be valuable translational research tools for development of new anti-migraine drugs.

• Authors: Sándor Farkas, Kata Bölcskei, Adrienn Markovics, Anita Varga, Ágnes Kis-Varga, Viktória Kormos, Balázs Gaszner, Csilla Horváth, Bernadett Tuka, János Tajti, Zsuzsanna Helyes
• Journal: Journal of pharmacological and toxicological methods (J Pharmacol Toxicol Methods) 2016 Jan-Feb Vol. 77 Pg. 33-44 ISSN: 1873-488X [Electronic] United States
• PMID: 26456070 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.

Chemical References

• Proto-Oncogene Proteins c-fos
• Vasodilator Agents
• Nitric Oxide
• Nitric Oxide Synthase
• Nitroglycerin

Topics

• Animals
• Disease Models, Animal
• Hyperalgesia (drug therapy, metabolism)
• Male
• Mice
• Migraine Disorders (drug therapy, metabolism)
• Nitric Oxide (metabolism)
• Nitric Oxide Synthase (metabolism)
• Nitroglycerin (pharmacology)
• Outcome Assessment, Health Care
• Proto-Oncogene Proteins c-fos (metabolism)
• Trigeminal Nuclei (drug effects, metabolism)
• Vasodilator Agents (pharmacology)